Spring Break
With stem cells, research trumps religion
Obama made the right move by bringing back federal funding for stem cell research.
By: Ian McPhail
Issue date: 3/25/09 Section: Opinion
Before an audience of scientists and researchers in the White House, President Barack Obama signed an executive order lifting a ban on federal funding restrictions for embryonic stem cell research. With $10 billion promised to medical research in the president's stimulus plan, it is likely that a good portion of that will be directed toward stem cells.
By reversing former President George W. Bush's religiously motivated prevention of progress, Obama has encouraged new opportunities for medicine. As there is legitimate hope that stem cell research can lead to treatments for Parkinson's diseases, Huntington's disease and liver damage, the U.S. government has a responsibility to its citizens to fund life-saving research.
Many, including Bush, have opposed stem cell research based on their moral position on abortion. Bush limited federal funding for stem cell research to only 21 pre-existing stem cell lines, but researchers needed to use hundreds of new stem cell lines from embryos. The reasoning behind these limitations was the ludicrous belief that funding for stem cell research would encourage more women to have abortions, as their fetuses would be put to a scientific use. Ignoring the fact that preventing citizens aiding scientific research through a completely legal action is as muddled and ignorant as the rest of Bush's presidency, the basic argument makes little sense. Abortion is mainly a last resort for women who are unequipped to deal with a child. The decision to abort is a personal one made by an individual, indifferent to the miniscule gain to science of one embryo.
Since 2001, when Bush's restriction was enacted, several states have launched initiatives to fund stem cell research. New York funded $600 million to stem cell research alone, in 2007, and voters in California pledged $3 billion in 2004, sponsoring 12 stem cell research centers. These investments should place the states in a better position to attract more federal money. Though Americans should be grateful that a few states were responsible enough to keep stem cell research on life support, the money given pales in comparison to the funds that could be given by the federal government. More importantly, private investors will be less fearful of putting their money in stem cell startups. Venture capitalists and big pharmaceutical companies have been reluctant to invest in stem cell companies due to concerns of further tightening of restrictions in the future.
By reversing former President George W. Bush's religiously motivated prevention of progress, Obama has encouraged new opportunities for medicine. As there is legitimate hope that stem cell research can lead to treatments for Parkinson's diseases, Huntington's disease and liver damage, the U.S. government has a responsibility to its citizens to fund life-saving research.
Many, including Bush, have opposed stem cell research based on their moral position on abortion. Bush limited federal funding for stem cell research to only 21 pre-existing stem cell lines, but researchers needed to use hundreds of new stem cell lines from embryos. The reasoning behind these limitations was the ludicrous belief that funding for stem cell research would encourage more women to have abortions, as their fetuses would be put to a scientific use. Ignoring the fact that preventing citizens aiding scientific research through a completely legal action is as muddled and ignorant as the rest of Bush's presidency, the basic argument makes little sense. Abortion is mainly a last resort for women who are unequipped to deal with a child. The decision to abort is a personal one made by an individual, indifferent to the miniscule gain to science of one embryo.
Since 2001, when Bush's restriction was enacted, several states have launched initiatives to fund stem cell research. New York funded $600 million to stem cell research alone, in 2007, and voters in California pledged $3 billion in 2004, sponsoring 12 stem cell research centers. These investments should place the states in a better position to attract more federal money. Though Americans should be grateful that a few states were responsible enough to keep stem cell research on life support, the money given pales in comparison to the funds that could be given by the federal government. More importantly, private investors will be less fearful of putting their money in stem cell startups. Venture capitalists and big pharmaceutical companies have been reluctant to invest in stem cell companies due to concerns of further tightening of restrictions in the future.
Be sure to include your name, major, and class year. Submissions without this information are subject to deletion.
By submitting a comment, you agree to thebatt.com's Terms of Use.
You may also send a Mail Call to The Battalion at mailcall@thebatt.com